VivoSeq
Other

Prostate

0

Pipeline Programs↗

9

Active Trials↗

5

Companies Involved↗

Prostate is an early-stage landscape with 0 programs across 5 companies. The most active players are GSK, Eli Lilly, Ipsen.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalEli Lilly logo

Eli Lilly

0 programs

PreclinicalIpsen logo

Ipsen

0 programs

PreclinicalU

US Oncology Research

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

44

clinical trials

Completed25 · 57%
Recruiting6 · 14%
Unknown status5 · 11%
Terminated3 · 7%
Withdrawn2 · 5%
Active, not recruiting2 · 5%
Other1 · 2%

Clinical Trials

Trial Activity

44 trials

Gadopiclenol in Contrast Enhanced MRI of the Prostate
Recruiting·—·Phase 4·NCT06226129·150 enrolled
A Study of Changes to Prostate Procedures
Recruiting·MMemorial Sloan Kettering Cancer Center·Phase 3·NCT06986083·800 enrolled
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Recruiting·EEmory University·Phase 2·NCT06865768·90 enrolled
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
Recruiting·—·Phase 4·NCT05629494·198 enrolled
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
Recruiting·—·Phase 2·NCT05761366·400 enrolled
A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate
Recruiting·TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine·Phase 4·NCT07357324·136 enrolled
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
Active, not recruiting·—·Phase 1·NCT05683964·9 enrolled
An Early Feasibility Study to Evaluate the Safety of the TheraSphere Prostate Cancer (PCa) Device in Patients With Clinically Localized Prostate Cancer
Active, not recruiting·BBoston Scientific Corporation·Preclinical·NCT06192758·36 enrolled
A Multicenter, Randomized Controlled Superiority Trial Comparing Robotic-Assisted Versus Expert Cognitive Fusion Prostate Biopsy in Obese Men
Not yet recruiting·SShanghai East Hospital·Preclinical·NCT07600216·570 enrolled
Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use
Completed·GSK logoGSK·N/A·NCT01332435·6,896 enrolled
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
Completed·UUniversity of Illinois at Chicago·N/A·NCT01594502·139 enrolled
Pazopanib, Docetaxel, Prednisone Prostate
Completed·—·Phase 1·NCT01385228·36 enrolled
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
Completed·GSK logoGSK·Phase 3·NCT00169585·240 enrolled
Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
Completed·SSeoul National University Hospital·Phase 4·NCT00880672·40 enrolled
Effects of ASA on Prostate Tissue
Completed·UUniversity of Washington·N/A·NCT00234299·60 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)